Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Role of proton-coupled folate transporter in pemetrexed resistance of mesothelioma: clinical evidence and new pharmacological tools

31 Aug 2017

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cystic Fibrosis Research Advances
Share to Occupational and environmental lung diseases
Share to Parathyroid Disorders and Treatments

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 28945836
DOI: 10.1093/annonc/mdx499

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Role of proton-coupled folate transporter in pemetrexed resistance of mesothelioma: clinical evidence and new pharmacological toolsPMID 28945836Read ↗

The human proton-coupled folate transporterSemantic proximity Read ↗

Folate transporter dynamics and therapy with classic and tumor-targeted antifolatesSemantic proximity Read ↗

Upregulation of Thymidylate Synthase Induces Pemetrexed Resistance in Malignant Pleural MesotheliomaSemantic proximity Read ↗

Folic acid phenotype (FAP) is a superior biomarker predicting response to pemetrexed-based chemotherapy in malignant pleural mesothelioma.Semantic proximity Read ↗

Membrane transporters and folate homeostasis: intestinal absorption and transport into systemic compartments and tissuesSemantic proximity Read ↗

Molecular Resistance Fingerprint of Pemetrexed and Platinum in a Long-Term Survivor of MesotheliomaSemantic proximity Read ↗

Circulating miR-22, miR-24 and miR-34a as novel predictive biomarkers to pemetrexed-based chemotherapy in advanced non small cell lung cancerSemantic proximity Read ↗

Significance of thymidylate synthase for resistance to pemetrexed in lung cancerSemantic proximity Read ↗

An epigenetic mechanism for capecitabine resistance in mesotheliomaSemantic proximity Read ↗

A P425R mutation of the proton-coupled folate transporter causing hereditary folate malabsorption produces a highly selective alteration in folate binding.Semantic proximity Read ↗

Human reduced folate carrier: translation of basic biology to cancer etiology and therapySemantic proximity Read ↗

The influence of platinum pathway polymorphisms on the outcome in patients with malignant mesotheliomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.